ArticleWorld journal of urology2025
Perioperative antibiotic prophylaxis in elective scrotal surgery: a retrospective cohort analysis of surgical site infections and risk factors.
Article in World journal of urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Heterogeneity in the perioperative management of asymptomatic bacteriuria across urological surgery: an international survey by the EAU-YAU Working Group on Infectious Diseases.World journal of urology · 2026Article
- [Perioperative and peri-interventional antibiotic prophylaxis: general and urology-specific recommendations from the German Interdisciplinary S3 guideline].Urologie (Heidelberg, Germany) · 2026Review
- Perioperative antibiotic prophylaxis in scrotal surgery: bridging the guideline gap between evidence and clinical practice.World journal of urology · 2025Article
Corrections and comments
- Commented on by
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo assess the effect of single-dose perioperative antibiotic prophylaxis (PAP) on surgical site infection (SSI) rates and related outcomes in elective scrotal or inguinal testicular surgery.
methodsRetrospective cohort study of patients who underwent elective clean scrotal or inguinal testicular surgery. Patients were stratified by PAP administration: single-dose PAP versus no PAP. Outcomes were SSI incidence, overall complications and severity (Clavien-Dindo classification and Comprehensive Complication Index [CCI]), length of stay, and readmission rates. Univariable regression analysis identified SSI risk factors in non-PAP patients.
resultsBetween 09/2018 and 09/2022, 105 (59%) patients received no PAP and 73 (41%) received PAP. The median follow-up of the total cohort was 10.3 months (interquartile range 1.1–21.9). Overall complication rates were similar between non-PAP and PAP groups (28% vs. 22%, p = 0.4) as were SSI (12% vs. 4%, p = 0.058), representing a threefold difference, though not statistically significant. Similarly, no significant differences could be shown in unplanned hospital visits (26% vs. 16%, p = 0.13), median CCI (26.2 vs. 26.2, p = 0.7), or specific complications including scrotal hematoma (10% vs. 6%, p = 0.2), swelling (2% vs. 4%, p = 0.4), prolonged pain (2% vs. 4%, p = 0.4), and wound dehiscence (3% vs. 2%, p = 0.6). In the non-PAP group, prolonged surgery duration (per minute increase; OR 1.04, 95% CI 1.01–1.07, p = 0.013) and postoperative scrotal hematoma (OR 5.4, 95% CI 1.23–21.86, p = 0.019) were independent risk factors for SSI development.
conclusionAlthough no statistically significant benefit of PAP was observed, the threefold lower rate of SSI in patients receiving PAP may indicate a potential effect and highlights the need for randomized trials with larger patient cohorts.
Indexed as
Identifiers
41006733What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.